Whether in the Courtroom or the Boardroom
we leverage cutting edge technology and our decades of experience to give you the advantage
Since 2005, we’ve had the privilege and honor of representing publicly traded and mid-sized businesses in diverse markets and industries, including Healthcare, Finance, Hospitality & Construction.
Practice Areas
Our seasoned team of attorneys are dedicated to delivering top-tier representation in various legal matters, leveraging our deep knowledge, skills, and experience. Whether you need assistance with complex disputes, transactions, or any other legal concerns, our firm is here to provide the expert guidance and advocacy you require.
Business
Proactive. Responsive. Problem-Solvers.
Securities
Safeguard Your Investments.
Biotech, Biologics, and Compliance
Navigating You Through the FDA Regulatory Process
Fintech
Unlocking the Future of Finance.
Healthcare
We Know the Business of Health.
Technology
Where innovation meets legal excellence.
Intellectual Property
Protecting Your Brand Identity.
Construction
Vigorous Defense. Cost-Effective Resolution.
Family Law
Effective Representation When It Matters Most
Mediation
Resolve Conflicts Peacefully.
Regulatory
Stop problems before they happen.
Aviation
Experienced. Dedicated. Knowledgeable.
Our Most Recent News
FinCEN’s New Interim Final Rule on Beneficial Ownership Information Reporting
On March 21, 2025, the Financial Crimes Enforcement Network (FinCEN) announced significant changes to the Beneficial Ownership Information Reporting (BOIR) requirements.
Understanding FinCEN’s Southwest Border Geographic Targeting Order for Money Service Businesses
On March 11, 2025, the Financial Crimes Enforcement Network (FinCEN) issued a Southwest Border Geographic Targeting Order (GTO) aimed at Money Service Businesses (MSBs).
BOI Filing Rule Will No Longer Be Enforced
On March 2, 2025, the Treasury has confirmed that FinCEN will no longer enforce any penalties or fines associated with the BOI filing requirement.
Artificial Intelligence for Drug & Biological Products – Credibility of AI Models for Context of Use – The “Model Risk” Paradigm
The FDA has recently issued draft guidance (non-binding recommendations) for drug and biological product sponsors and computer programmers regarding the use of Machine Learning (ML) and artificial intelligence (AI) to support regulatory decision-making about the safety, effectiveness, or quality of drugs.
Artificial Intelligence for Drug & Biological Products – Credibility of AI Models for Context of Use – The “Model Risk” Paradigm
Artificial Intelligence for Drug & Biological Products – Credibility of AI Models for Context of Use – The “Model Risk” Paradigm. The FDA has recently issued draft guidance (non-binding recommendations) for drug and biological product sponsors and computer...
For Better or Worse
Family Law Happy Hour
Episode 5: Child Support, Modifications & Celebrity Settlements
Listen in as Tenny and Shayda tackle child support and the multimillion-dollar settlements in celebrity cases. In this episode you’ll learn how child support is calculated in California, why the law is considered gender-neutral, and the time-sensitivity of modifications. Wonder how much Nick Cannon is paying annually in child support? Tune in to get the full scoop on that and a lot more!
From Our Clients